Regeneron (NASDAQ: REGN) reported Q2 EPS of $10.24, $0.39 better than the analyst estimate of $9.85. Revenue for the quarter came in at $3.16 billion versus the consensus estimate of $3.03 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.